The year 2026 marks a significant turning point for global cosmetics regulation, transitioning from the creation of new laws to their actual implementation. Key changes in regulations such as the EU's ingredient restrictions, MoCRA in the U.S., China's CSAR, and South Korea's cosmetics safety assessment law highlight the urgent need for companies to redefine their compliance strategies.
In the EU, the phase-out deadlines for 4-Methylbenzylidene Camphor (4-MBC) will take effect, coinciding with the introduction of expanded allergen labeling requirements. From May 1, 2026, products containing 4-MBC will no longer be allowed on the market, requiring companies to proactively manage their inventory and formulation. Additionally, Regulation (EU) 2023/1545 imposes new labeling requirements that companies must adhere to by July 31, 2026, emphasizing the need for detailed allergen declaration from suppliers.
In the UK, post-Brexit regulations are diverging from EU standards, necessitating tailored compliance strategies. By 2026, products containing 4-MBC will be classified as prohibited ingredients, while stricter rules on formaldehyde-releasing preservatives will also come into effect. This reflects a broader trend where differing regulatory timelines mandate unique approaches between the UK and EU markets.
The U.S. will also see important regulatory shifts with MoCRA, requiring not just initial registration but ongoing management of compliance information. Companies will need to focus on the permanence of their registration status as well as safety substantiation, aligning their practices with the FDA's more detailed guidelines set to be clarified by January 2026.
In China, regulatory changes will require companies to adapt beyond NMPA regulations, integrating new electronic labeling requirements and advanced assessments that increasingly rely on non-animal testing methods. The challenge lies in balancing compliance with both NMPA and MEE regulations as the landscape becomes more convoluted.
Japan's regulatory landscape is evolving with a focus on enhancing safety assessment methodologies. The emphasis is shifting from mere compliance to employing robust scientific evaluations that could align with global standards, indicating an expanding need for comprehensive datasets that can support safety claims across diverse markets.
For South Korea, 2026 signifies not just a transition but a concrete implementation of its safety assessment system, with new guidelines set to be established in mid-2026. Companies must prepare both their product formulations and documentation to ensure they meet the revised criteria, keeping in mind the first application phases beginning in 2028.
As the year approaches, the imperative for companies across the industry is clear: establishing a cohesive and robust data management strategy will be crucial for navigating the complex global compliance landscape ahead. Businesses should consider developing a central repository of scientific data that can fulfill the documentation requirements across multiple jurisdictions, thereby streamlining their regulatory processes and reducing redundancies.
